McCarthy J R, Moore J L, Wysong D V
J Med Chem. 1977 Oct;20(10):1272-6. doi: 10.1021/jm00220a009.
A new synthesis of Mannich bases of rifamycin SV using the Borch2 procedure with rifaldehyde is described. This new synthesis offers two advantages over the previously published method. It provides a route to monoalkyl-aminomethylrifamycins (le-h) and to unsubstituted aminomethylrifamycins that were not accessible by the old procedure. The new method also offers a preparative route to Mannich bases 1a and 1b were needed in multigram quantities for biological testing. In addition, the cyclization of certain of the monoalkylaminomethylrifamycins to the novel N,15-didehydro-15-epi[methano(alkylimino)]rifamycin SV derivatives (2) is described. The anticellular and antiviral effects of representatives of both series of compounds against cultured mouse cells and murine oncornavirus are are discussed.
描述了一种使用Borch2方法和利福醛合成利福霉素SV的曼尼希碱的新方法。这种新合成方法相对于先前发表的方法有两个优点。它提供了一条制备单烷基-氨基甲基利福霉素(le-h)和未取代的氨基甲基利福霉素的途径,而旧方法无法获得这些产物。新方法还为生物测试所需的多克量的曼尼希碱1a和1b提供了一条制备途径。此外,还描述了某些单烷基氨基甲基利福霉素环化生成新型N,15-二脱氢-15-表[亚甲基(烷基亚氨基)]利福霉素SV衍生物(2)的过程。讨论了这两个系列化合物的代表对培养的小鼠细胞和鼠源肿瘤病毒的抗细胞和抗病毒作用。